TrialPloS one2019

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.

Cristina Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.